A nonNMDA antagonist, GYKI 52466 improves microscopic O2 balance in the cortex during focal cerebral ischemia

Neurological Research

Volumn 21, Issue 3, 1999, Pages 299-304

  Chi, Oak Z ^a   Chang, Qiang ^a   Wang, Guolin ^b   Liu, Xia ^a   Weiss, Harvey R ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b Medical University   (China)

Author keywords

AMPA receptor; Brain; Cerebral oxygen consumption; Cerebral oxygen supply; Focal cerebral ischemia; GYKI 52466

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; AMPA RECEPTOR; IODOPHENAZONE C 14; OXYGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BLOOD GAS; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; BRAIN OXYGEN CONSUMPTION; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MICROSPECTROPHOTOMETRY; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; OXYGEN SATURATION; RAT;

EID: 0032964688     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1080/01616412.1999.11740935     Document Type: Article

References (30)

1. Block F, Schmitt W, Schwarz M. Pretreatment but not posttreatment with GYKI 52466 reducer, functional deficits and neuronal damage after global ischemia in rats. J Neurol Sci 1996; 139: 167-172
2. Buchan AM, Lesiuk H, Barnes KA, Li H, Huang ZG, Smith KE, Xue D. AMPA antagonists: Do they hold more promise for clinical stroke trials than NMDA antagonists? Stroke 1993; 24: 1148-1152
3. Le Peillet E, Arvin B, Moncada C, Meldrum BS. The non-NMDA antagonists, NBQX and GYKI 52466, protect against cortical and striatal cell loss following transient global ischaemia in the rat. Brain Res 1992; 571: 115-120
4. Smith SE, Meldrum BS. Cerebroprotective effect of a non-NMDA antagonist, GYKI 52466, after focal ischemia in rats. Stroke 1992; 23: 861-864
5. Xue D, Huang ZG, Barnes K, Lesiuk HJ, Smith KE, Buchan AM. Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction. J Cereb Blood Flow Metab 1994; 14: 252-261
6. Ames A, Li YY. Energy requirements of glutamatergic pathways in rabbit retina. J Neurosci 1992; 12: 4234-4242
7. Nehls DG, Park CK, MacCormack AG, McCulloch J. The effects of N-methyl-D-aspartate receptor blockade with MK-801 upon the relationship between cerebral blood flow and glucose utilization. Brain Res 1990; 511: 271-279
8. Nishizaki T, Okada Y. Effect of excitatory amino acids on the oxygen consumption of hippocampal slices from the guinea pig. Brain Res 1988; 452: 11-20
9. Turski L, Turski WA. Towards an understanding of the role of glutamate in neurodegenerative disorders: Energy metabolism and neuropathology. Experientia 1993; 49: 1064-1072
10. 2 consumption and blood flow in rat. Brain Res 1996; 730: 838-845
11. Chi OZ, Anwar M, Sinha AK, Weiss HR. Effect of MK-801 on cerebral regional oxygen consumption in focal cerebral ischemia in rats. Circ Res 1991; 69: 414-420
12. Tarnawa I, Farkas S, Berzsenyi P, Pataki A, Andrasi F. Electrophysiological studies with 2,3-benzodiazepine muscle relaxant: GYKI 52466. Eur J Pharmacol 1989; 167: 193-199
13. Chapman AG, Smith SE, Meldrum BS. The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice. Epilepsy Res 1991; 9: 92-96
14. Loscher W, Honack D. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice. Comparison with diazepam and interactions with flumazenil. Br J Pharmacol 1994; 113: 1349-1357
15. Block F, Schwarz M. The depressant effect of GYKI 52466 on spinal reflex transmission in rats is mediated via non-NMDA and benzodiazepine receptors. Eur J Pharmacol 1994; 256: 149-153
16. Ouardouz M, Durand J. GYKI 52466 antagonizes glutamate responses but not NMDA and kainate responses in rat abducens motor neurons. Neurosci Lett 1991; 125: 5-8
17. Donevan SD, Rogawski MA. GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses. Neuron 1993; 10: 51-59
18. 2 supply and consumption determined microspectrophotometrically. Am J Physiol 1987; 253: H454-H460
19. Chi OZ, Wei HM, O'Hara DA, Sinha AK, Weiss HR. Effects of pentobarbital and isoflurane on regional cerebral oxygen extraction and consumption with middle cerebral artery occlusion in rats. Anesthesiology 1993; 79: 299-305
20. Chi OZ, Wei HM, Tse J, Klein SL, Weiss HR. Cerebral microregional oxygen balance during chronic versus acute hypertension in middle cerebral artery occluded rats. Anesth Analg 1996; 82: 587-592
21. Brint S, Jacewicz M, Kiessling M, Tanabe J, Pulsinelli W. Focal brain ischemia in the rat: Methods for reproducible neocortical infarction using tandem occlusion of the distal middle cerebral and ipsilateral common carotid arteries. J Cereb Blood Flow Metab 1988; 8: 474-485
22. Chen ST, Hsu CY, Hogan EL, Maricq H, Balentine JD. A model of focal ischemic stroke in the rat: Reproducible extensive cortical infarction. Stroke 1986; 17: 738-743
23. 14-antipyrine. Am J Physiol 1978; 234: H59-H66
24. Castillo J, Davalos A, Naveiro J, Noya M. Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke. Stroke 1996; 27: 1060-1065
25. MacKay KB, Patel TR, Galbraith SL, Woodruff GN, McCulloch J. The relationship between glutamate release and cerebral blood flow after focal cerebral ischaemia in the cat: Effect of pretreatment with enadoline (a Kapa receptor agonist). Brain Res 1996; 712: 329-334
26. Tarnawa I, Engberg I, Flatman JA. GYKI 52466, an inhibitor of spinal reflexes is a potent quisqualate antagonist. In: Lubec G, Rosenthal GA, eds. Amino Acids: Chemistry, Biology and Medicine, Leiden: ESCOM, 1990: pp. 538-546
27. i-protein in cortical neurons. Nature 1997; 389: 502-504
28. 125I]Iodo-MK-801 to the NMDA receptor-channel complex in rat brain. Nucl Med Biol 1992; 19: 319-326
29. 125I]-iodo-MK-801 binding to thin sections of rat brain. J Neurosci Meth 1993; 46: 17-21
30. Martin LJ, Blackstone CD, Levey Al, Huganir RL, Price DL. AMPA glutamate receptor subunits are differentially distributed in rat brain. Neuroscience 1993; 53: 327-358